Capricor Therapeutics (4LN2.F) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.49
-0.38
-0.26
-0.15

Details

Expected EPS
-0.40979315999999993
Actual EPS
-0.49071869999999995
Surprise EPS
-0.08
Surprise Percent
+19.75%

Description

Capricor Therapeutics (4LN2.F) has reported earnings of -0.49071869999999995 per share for Q3 2025.

0 Comments

Share your thoughts